You may be right on FDA requiring a new trial, but if they had the Dr prescribe LR-etEpa DAW (Once approved) they should increase sales and therefore begin to "market" the new formulation. Currently they can't educate anybody as it would benefit both V and GV. That would be a high cost for 50% of the current marketshare.